These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1163650)

  • 21. [Tryptophan in hepatic encephalopathy].
    Esquivel López A; Austria Mireles R; Coronado Perdomo D
    Rev Gastroenterol Mex; 1983; 48(2):91-4. PubMed ID: 6622904
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of protein metabolism in 204 liver cirrhotics with and without hepatic encephalopathy. I. Clinical and general biochemical findings.
    Müting D; Kalk JF; Koussouris P; Motschenbacher MT; Rausche A
    Hepatogastroenterology; 1986 Apr; 33(2):61-5. PubMed ID: 3721388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Several factors in the pathogenesis of hepatic failure in patients with liver cirrhosis and bleeding from esophageal and gastric varicose veins].
    Bour AV; Manuk'ian GV; Umruzakov IU; Shertsinger AG
    Anesteziol Reanimatol; 1993; (2):32-4. PubMed ID: 7943876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis.
    Marchesini G; Fabbri A; Bianchi G; Brizi M; Zoli M
    Hepatology; 1996 May; 23(5):1084-92. PubMed ID: 8621138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of antibiotics in the management of hepatic encephalopathy.
    Maddrey WC
    Rev Gastroenterol Disord; 2005; 5 Suppl 1():S3-9. PubMed ID: 15976746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pathogenesis of portal systemic encephalopathy].
    García Compeán D; Valadez Castillo R; Barragán RF
    Rev Invest Clin; 1990 Jul; 42 Suppl():113-9. PubMed ID: 19256149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The distribution of ammonium nitrogen in venous blood, ascites, and cerebrospinal fluid in cases of hepatic cirrhosis.
    Ciplea A; Baltă N; Stancu C; Drăgulescu N
    Rev Roum Physiol; 1970; 7(2):163-70. PubMed ID: 5492066
    [No Abstract]   [Full Text] [Related]  

  • 28. [Neurologic complications of liver diseases].
    Wewalka F
    Wien Z Nervenheilkd Grenzgeb; 1971; 29(1):95-106. PubMed ID: 4256005
    [No Abstract]   [Full Text] [Related]  

  • 29. [The response to combined therapy of hepatic encephalopathy in patients with hepatic cirrhosis].
    Maev IV; V'iuchnova ES; Lebedeva EG; Iakovenko EI; Dicheva DT
    Klin Med (Mosk); 2002; 80(5):42-5. PubMed ID: 12087887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain energy metabolism in hepatic coma.
    Maiolo AT; Porro GB; Galli C; Sessa M; Polli EE
    Exp Biol Med; 1971; 4():52-70. PubMed ID: 5162460
    [No Abstract]   [Full Text] [Related]  

  • 31. [Role of zinc deficiency in development of hepatic encephalopathy in patients with liver cyrrosis].
    Shaposhnikova NA
    Eksp Klin Gastroenterol; 2007; (3):108-12. PubMed ID: 17937015
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pathogenesis of hepatic coma].
    Capocaccia L; Rossi Fanelli F; Cascino A; Cangiano C; Calcaterra V; de Conciliis D; Gentile S; Merli M; Riggio O; Stortoni M; Giunchi G
    Recenti Prog Med; 1981 Apr; 70(4):358-99. PubMed ID: 6114522
    [No Abstract]   [Full Text] [Related]  

  • 33. [Portocaval encephalopathy. Dietetics and treatments].
    Segrestaa JM; Caulin C
    Rev Prat; 1972 Feb; 22(6):765-72. PubMed ID: 5064410
    [No Abstract]   [Full Text] [Related]  

  • 34. The in vitro production of ammonium and amines by intestinal bacteria in relation to nitrogen toxicity as a factor in hepatic coma.
    PHEAR EA; RUEBNER B
    Br J Exp Pathol; 1956 Jun; 37(3):253-62. PubMed ID: 13342350
    [No Abstract]   [Full Text] [Related]  

  • 35. Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS.
    Olde Damink SW; Jalan R; Redhead DN; Hayes PC; Deutz NE; Soeters PB
    Hepatology; 2002 Nov; 36(5):1163-71. PubMed ID: 12395326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Exchange transfusion in the therapy of acute hepatic coma].
    Iaschi P
    Clin Ter; 1969 May; 49(3):275-85. PubMed ID: 4916101
    [No Abstract]   [Full Text] [Related]  

  • 37. Immune inhibition of urea breakdown in patients with cirrhosis.
    Thomson A; Holmes AW
    Gastroenterology; 1967 Jan; 52(1):14-7. PubMed ID: 6018366
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of protein metabolism in 204 liver cirrhotics with and without hepatic encephalopathy. II. Amino acids, free phenols and indoles.
    Müting D; Perisoara A; Baum G; Flasshoff HJ; Bucsis L
    Hepatogastroenterology; 1986 Apr; 33(2):66-70. PubMed ID: 3721389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypokalemia-induced hepatic coma in cirrhosis. Occurrence despite neomycin therapy.
    Artz SA; Paes IC; Faloon WW
    Gastroenterology; 1966 Dec; 51(6):1046-53. PubMed ID: 5958605
    [No Abstract]   [Full Text] [Related]  

  • 40. [Controlled protein administration diet and the prevention of hepatic encephalopathy].
    Strata A; Giuberti T; Magnati G; Regolisti M; Sacchini D; Fiaccadori F
    Minerva Dietol Gastroenterol; 1984; 30(3):245-50. PubMed ID: 6504373
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.